Market Overview Biologic innovation and remission-focused therapy represent transformative capabilities advancing ulcerative colitis treatment through advanced TNF-inhibitors, anti-integrin agents, JAK inhibitors, and personalized biologic selection enabling superior remission rates and durable disease control. The Ulcerative Colitis Market transformation toward biologic sophistication...